Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Cancers (Basel). 2022 Dec 12;14(24):6127. doi: 10.3390/cancers14246127.
Cancers (Basel). 2022.
PMID: 36551611
Free PMC article.
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations.
Winfree KB, Molife C, Peterson PM, Chen Y, Visseren-Grul CM, Leusch MS, Beyrer J, Dimou A.
Winfree KB, et al. Among authors: leusch ms.
Future Oncol. 2021 Aug;17(22):2867-2881. doi: 10.2217/fon-2021-0218. Epub 2021 Apr 19.
Future Oncol. 2021.
PMID: 33866796
Item in Clipboard
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.
Goulding RE, Chenoweth M, Carter GC, Boye ME, Sheffield KM, John WJ, Leusch MS, Muehlenbein CE, Li L, Jen MH, Rojubally A, Jansen J, Druyts E.
Goulding RE, et al.
Cancer Treat Res Commun. 2020;24:100200. doi: 10.1016/j.ctarc.2020.100200. Epub 2020 Jul 25.
Cancer Treat Res Commun. 2020.
PMID: 32750661
Free article.
Item in Clipboard
Cite
Cite